AzTrials
AzTrials

SatietyNCT03207607

Mid-morning Gel Snacks on Subjective Appetite, Glycemic and Insulin Responses, and Food Intake

A study testing Maltodextrin snack, Whey protein snack and Oat snack in people with Satiety and Food Intake, run by Toronto Metropolitan University at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study was to determine the effect of mid-morning gel snacks on subjective appetite, glucose and insulin responses, and food intake in healthy weight young adults. Read more about this study

Who is it for?
Ages 18 to 30 yearsHealthy volunteers can take part
Conditions the study is for
Satiety, Food Intake
What is being tested?
Maltodextrin snack, Whey protein snack and Oat snack
Could I receive a placebo?
No, everyone receives an active treatment
How many people
23 participants
Where
1 siteCanada
Study dates
Feb 2016to Aug 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • be between 18 and 30 years of age
  • be healthy, non-smoking and not be taking any medications, including birth control
  • body mass index (BMI) between 20 and 24.9

Who cannot join

  • fasting plasma glucose >5.5 mmol/L
  • health problems including previously diagnosed diabetes, known or uncertain pregnancy status at screening, gastrointestinal disease, liver or kidney disease
  • major medical or surgical event within the past 6 months
  • current or recent dieting
  • breakfast skipping
  • receiving any medications
Show all 10Show fewer
  • menstrual irregularities
  • food sensitivities, allergies, intolerances, or dietary restrictions to foods including: cereal, orange juice, dairy, oat, coconut oil, honey, apple, pineapple, strawberry, and pear
  • behavioural or emotional problems
  • alcohol consumption >7 beverages/week

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • School of Nutrition, Ryerson University

    Toronto, Ontario, M5B 2K3

Other trials in Canada

About this study

Official title: The Effect of Mid-Morning Gel Snacks on Subjective Appetite, Glycemic and Insulin Responses, and Food Intake in Healthy Adults

The purpose of this study was to determine the effect of mid-morning gel snacks on subjective appetite, glucose and insulin responses, and food intake in healthy weight young adults.

Read the detailed description

23 (14 male, 9 female) healthy, non-smoking human subjects aged 18-30 years with a body mass index (BMI) between 20 and 24.9 were recruited in the experiment. Five gel snacks including a control snack and four modified snacks containing whey protein, oats, coconut oil or maltodextrin were tested. On six separate mornings, at least 3 days apart and after a 12 hours overnight fast, each participant consumed a standardized breakfast of cereal, milk, and orange juice at home, then arrived in the lab 2 hours after breakfast to receive one of the five test snack treatments or skip snack. Subjective appetite by a 100 mm visual analogue scale (VAS) was measured at baseline (0 min) and after each treatment up to 2 h (15, 30, 60, 90, and 120 min). Blood glucose and insulin concentrations were measured via finger-prick at the same time VAS measurements were taken. Food intake was measured via ad libitum pizza lunch.

Conditions
Satiety, Food Intake
Being tested
Control snack, Maltodextrin snack, Whey protein snack, Oat snack, Coconut oil snack
Keywords
Adults, Snacks, Appetite, Blood glucose, Insulin
Medical subject headings
Insulin Resistance

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Control snackOther

    Isovolumetric (238.4g) gel snack prepared by real fruits (186.2kcal)

  • Maltodextrin snackOther

    Isovolumetric (238.4g) gel snack with maltodextrin (271.8kcal)

  • Whey protein snackOther

    Isovolumetric (238.4g) gel snack with whey protein (201.8kcal)

  • Oat snackOther

    Isovolumetric (238.4g) gel snack with oats and maltodextrin (275.8kcal)

  • Coconut oil snackOther

    Isovolumetric (238.4g) gel snack with coconut oil (276.4kcal)

  • Snack skippingOther

    no snack

Study groups in NCT03207607
Study groupRoleWhat they receive
Control snackExperimentalParticipants received control snacks prepared by real fruits (pear, orange and mango)
Receives: Other: Control snack
Maltodextrin snackExperimentalParticipants received maltodextrin snacks (maltodextrin + control snack)
Receives: Other: Maltodextrin snack
Whey protein snackExperimentalParticipants received whey protein snacks (whey protein + control snack)
Receives: Other: Whey protein snack
Oat snackExperimentalParticipants received oat snacks (oat + maltodextrin + control snack)
Receives: Other: Oat snack
Coconut oil snackExperimentalParticipants received coconut oil snacks (coconut oil + control snack)
Receives: Other: Coconut oil snack
Snack skippingExperimentalParticipants received snack skipping
Receives: Other: Snack skipping

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Subjective Appetite

    Participants completed subjective ratings on appetite (e.g., desire to eat, hunger, fullness, prospective food consumption) and well-being at baseline (0 min), 15, 30, 45, 60, 90, and 120 min after snack consumption, as well as immediately following lunch.

    Measured: Change from baseline over 120 minutes

Secondary outcomes (3)
  1. Blood Glucose Response

    Blood was collected at baseline (0min), 15, 30, 45, 60, 90, and 120 min after snack consumption, as well as immediately following lunch to observe glycemic responses to gel snacks

    Measured: Change from baseline over 120 minutes

  2. Blood Insulin Response

    Blood was collected at baseline (0 min), 15, 30, 45, 60, 90, and 120 min after meal consumption, as well as immediately following lunch, to observe insulin responses to gel snacks

    Measured: Change from baseline over 120 minutes

  3. Food Intake

    Participants consumed an ad libitum pizza lunch at 120 minutes

    Measured: 30 min

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jul 2017
  2. Study startFeb 2016
  3. Primary completionAug 2016
  4. Study completionAug 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
23 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03207607
Sponsor's protocol ID
REB2015-405
Status last verified
Jun 2017
First submitted
29 Jun 2017
Last updated
5 Jul 2017
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Maltodextrin snack, Whey protein snack and Oat snack in people with Satiety and Food Intake, run by Toronto Metropolitan University at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Jul 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Subjective Appetite (time frame: Change from baseline over 120 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jul 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in